AMGOVO

Preparations for treatment of human diseases of the autonomic, circulatory, and central nervous system; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations and substances for the treatment of neurogenic orthostatic hypotension and for the prevention and treatment of low blood pressure; pharmaceutical preparations and substances in the nature of anti-hypotensive and vasopressor agents; pharmaceutical preparations and substances for the treatment of Parkinson's disease and disorders; pharmaceutical preparations and substances for the prevention and treatment of dizziness and light-headedness; pharmaceutical preparations and substances for the treatment of disorders characterized by a deficiency of norepinephrine; pharmaceutical preparations and substances for the treatment of multiple system atrophy; pharmaceutical preparations and substances for the treatment of movement disorders; pharmaceutical preparations and substances for the treatment of neurodegenerative disease.